Body mass index, weight loss, and progression and mortality in metastatic colorectal cancer (Alliance)
- Citation:
- Cancer Res vol 79 (13) abst 3285
- Meeting Instance:
- AACR 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3138
- Pharmas:
- BMS, Genentech, Myriad, Pfizer, Sanofi
- Grants:
- U10CA180821, U10CA180882, U10CA180820, U10CA180888
- Corr. Author:
- Authors:
- Brendan J. Guercio Sui Zhang Alan P. Venook Fang-Shu Ou Donna Niedzwiecki Heinz-Josef Lenz Federico Innocenti Michelle R. Mahoney Bert H. O'Neil James E. Shaw Blase N. Polite Howard S. Hochster James N. Atkins Richard M. Goldberg Robert J. Mayer Charles D. Blanke Charles S. Fuchs Jeffrey A. Meyerhardt
- Networks:
- CA011, CA824, CAPITAL, LAPS-CT018, LAPS-IL057, LAPS-IN007, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, NC002, NY167, OR013
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Colorectal adenocarcinoma, Metastatic tumors, Body mass index, Survival